A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation

European Respiratory Journal

Volumn 10, Issue 7, 1997, Pages 1585-1590

  Blondal T ^a,b   Franzon, M ^c   Westint, A ^d  

^a Reykjavik Health Care Center   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c PFIZER INC   (United States)

^d Pharmacia & Upjohn AB   (Sweden)

Author keywords

Nicotine; Nicotine delivery system; Nicotine nasal spray; Smoking cessation

Indexed keywords

NICOTINE; NOSE SPRAY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EYE IRRITATION; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE IRRITATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SMOKING; SMOKING CESSATION; SNEEZING; SWEATING; VERTIGO;

ADMINISTRATION, INTRANASAL; ADULT; AEROSOLS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NICOTINE; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0030859271     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10071585     Document Type: Article

References (15)

1. Henningfield JE. Nicotine medications for smoking cessation. N Eng J Med 1995; 333: 1196-1203.
2. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992; 44: 498-527.
3. Sutherland G, Stapleton JA, Russell MAH, et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 1992; 340: 324-329.
4. Hjalmarson A, Franzon M, Westin A, Wiklund O. Effect of nicotine nasal spray on smoking cessation: a randomised, placebo-controlled, double-blind study. Arch Intern Med 1994; 154: 2567-2572.
5. Schneider NG, Olmstead R, Mody FV, et al. Efficiency of a nicotine nasal spray in smoking cessation: a placebo controlled, double-blind trial. Addiction 1995; 90: 1671-1682.
6. Tönnesen P, Nörregaard J, Mikkelsen K, Jörgensen S, Nilsson F. A double-blind trial of nicotine inhaler for smoking cessation. JAMA 1993; 269: 1268-1271.
7. Schneider NG, Lunell E, Olmstead RE. Fagerström KO. Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems. Clin Pharmacokinet 1996; 31: 65-80.
8. Fagerström KO, Schneider NG. Measuring Nicotine Dependence: a review of the Fagerström tolerance questionnaire. J Behav Med 1989; 12: 159-181.
9. Jarvis MJ, Tunstall-Pedhoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987; 77: 1435-1438.
10. Falkman SE, Burrows IE, Lundgren RA, Page BFJ. A modified procedure for determination of nicotine in blood. Analyst 1975; 100: 99-104.
11. Eremin SA, Coxon RE, Colbert DL, Landon J, Smith DS. Urinary cotinine fluoroimmunoassay for smoking status screening adapted to an automated analyser. Analyst 1992; 117: 697-699.
12. Norusis MJ. SPSS® for Windows. Advanced Statistics, Release 6.0. Chicago, IL, SPSS Inc., 1993; pp. 247-253.
13. Benowitz NL. Pharmacodynamics of nicotine: implications for rational treatment of nicotine addiction. Br J Addict 1991; 86: 495-499.
14. Fagerström KO, Schneider NG, Lunell E. Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms. Psychopharmacology 1993; 111: 271-277.
15. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995; 24: 41-47.